Irina Pestrikova - 18 Jun 2021 Form 3 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Senior Director, Finance
Signature
/s/ Irina Pestrikova by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
18 Jun 2021
Net transactions value
$0
Form type
3
Filing time
22 Jun 2021, 16:02:08 UTC
Next filing
30 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NDRA Stock Options 18 Jun 2021 Common Stock 4,000 $0.7000 Direct F1
holding NDRA Stock Options 18 Jun 2021 Common Stock 4,000 $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option grant becomes exercisable with respect to 1,334 shares of common stock on the first anniversary of the grant date and with respect to 1,333 shares of common stock on the second and third anniversary of the grant date.